Pharmafile Logo
Pharmafocus logo
Advanced Search

intellectual property

Showing 8 posts of 8 posts found.

Latham & Watkins appoints Lydia Torne as life sciences and IP partner

October 3, 2025
Latham & Watkins, intellectual property

Appointment brings specialist healthcare IP commercialisation expertise to the firm Latham & Watkins has appointed Lydia Torne as a partner …

Appointment
falsified_medicines

Counterfeit drugs – countering the lies

February 4, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Counterfeit drugs, IP, counterfeit medicines, falsified medicines, intellectual property, law, legal, patent

As the Falsified Medicines Directive comes into effect in February 2019, Louis Goss fact checks ‘common sense’ claims on counterfeit …

Feature

Fewer patents being filed for novel infectious diseases and AMR diagnostic technologies; US leads, UK follows

October 17, 2018
Research and Development AMR, IP, intellectual property, patents

Fewer patents are being filed for point-of-care diagnostic technologies aimed at tackling infectious diseases and antimicrobial resistance (AMR), according to …

News

Health innovation system is broken and failing patients, new report argues

October 15, 2018
Sales and Marketing IP, industry, intellectual property, priofit, research

The pharmaceutical industry is incentivised to set high prices and deliver short-term returns to shareholders, rather than focusing on riskier, …

News
16193381408_003eb2fdc9_z1

Irish trade lobby warns EU amendments could threaten pharma industry in Ireland, critics contest

August 6, 2018
Sales and Marketing EU, IPHA, Ireland, biosimilars, generics, intellectual property, trade lobby

The Irish Pharmaceutical Healthcare Association (IPHA) has warned that changes to existing intellectual property legislation could threaten innovation and deter …

News
BIS

UK second in global innovation index

September 18, 2015
Medical Communications, Research and Development Global Innovation Index, World Intellectual Property Organisation, innovation, intellectual property, patents, wipo

The UK – along with Switzerland, Sweden, the Netherlands and the US – is in the world’s five most innovative …

News
clinical trial

The biggest side-effect of making medicine

September 16, 2015
Research and Development evergreening, intellectual property, patent

International intellectual property regulations are doing serious damage to the pharmaceutical industry and, by extension, to the health of people …

Feature

India’s Nexavar patent ruling disturbs pharma

March 12, 2012
Sales and Marketing India, emerging markets, intellectual property, patents

India is to allow Bayer’s cancer treatment Nexavar to be subject to a compulsory licence, allowing a generic firm to …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025